GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $402,000 | -29.7% | 9,226 | -29.7% | 0.00% | -20.0% |
| Q1 2022 | $572,000 | -17.6% | 13,121 | -16.6% | 0.01% | -16.7% |
| Q4 2021 | $694,000 | -31.8% | 15,738 | -40.9% | 0.01% | -33.3% |
| Q3 2021 | $1,018,000 | +17.1% | 26,635 | +22.1% | 0.01% | +28.6% |
| Q2 2021 | $869,000 | +11.0% | 21,812 | -0.6% | 0.01% | 0.0% |
| Q1 2021 | $783,000 | -14.7% | 21,936 | -12.0% | 0.01% | -22.2% |
| Q4 2020 | $918,000 | -32.9% | 24,935 | -31.4% | 0.01% | -40.0% |
| Q3 2020 | $1,368,000 | -15.6% | 36,337 | -8.5% | 0.02% | -16.7% |
| Q2 2020 | $1,620,000 | +21.8% | 39,720 | +13.2% | 0.02% | +12.5% |
| Q1 2020 | $1,330,000 | -19.2% | 35,093 | +0.2% | 0.02% | +23.1% |
| Q4 2019 | $1,647,000 | -9.1% | 35,040 | -17.4% | 0.01% | -13.3% |
| Q3 2019 | $1,811,000 | +11.1% | 42,440 | +4.2% | 0.02% | +25.0% |
| Q2 2019 | $1,630,000 | -13.7% | 40,740 | -9.8% | 0.01% | -14.3% |
| Q1 2019 | $1,888,000 | – | 45,180 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |